- $9.24bn
- $9.63bn
- $501.02m
- 71
- 19
- 99
- 69
Annual income statement for IREN, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | R2023 June 30th | R2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
Standards: | IFRS | IFRS | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.9 | 59 | 75.5 | 187 | 501 |
Cost of Revenue | |||||
Gross Profit | — | — | 36.1 | 100 | 342 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.42 | 58.7 | 229 | 214 | 475 |
Operating Profit | -0.524 | 0.295 | -154 | -27.2 | 26.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -59.2 | -417 | -169 | -25.5 | 93.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -60.4 | -420 | -172 | -28.9 | 86.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -60.4 | -420 | -172 | -28.9 | 86.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -60.4 | -420 | -172 | -28.9 | 86.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.09 | -10.2 | -1.83 | -0.269 | 0.51 |
Dividends per Share |